Our inaugural 2024 event will spotlight extraordinary collaborations that have delivered cutting edge scientific and medical results. The presentations will provide both overview and detail, suitable both for experts and those who wish to better understand the latest innovations in global health.
If you have an interest in the development of scientific and healthcare technology, you’ll find Collaborate a fun, enlightening and educational event. Tickets are extremely limited, so if interested, please apply today.
Origin Sciences is a privately funded medical technology company based in Cambridge, UK. The innovative work carried out by Origin is focused on the diagnosis and monitoring of diseases of the gastrointestinal tract with an early focus on colorectal cancer (CRC) diagnostics – set to satisfy a desperate unmet need globally.
Collaborate presents Origin Sciences as part of its MedTech showcase, demonstrating how carefully managed collaboration can refine, accelerate and improve technical developments from conception to implementation.
Origin are on track to launch Oricol™ Preview in 2025. Oricol™ Preview is a diagnostic tool (in vitro diagnostic) that uses the rectal mucus as a rich and informative specimen for a variety of proprietary and highly effective laboratory assays. Origin is also home to the Oricol™ mucus collection device – a minimally invasive clinical test that is paving the way towards a very new era in gastrointestinal disease diagnostics and monitoring.
The innovations and technologies developed by Origin are now being utilised for Ellele Health. Ellele follow the founding principles of Oricol™ Preview but are applied exclusively to women’s health applications.
Lord Prior is Deputy Chairman UK and Global Senior Advisor at Lazard.
He was educated at Cambridge University and subsequently qualified as a barrister. He trained in finance at Lehman Brothers and Lazard Freres in New York before holding a number of senior positions within the industrial sector, including British Steel, where he was Commercial Director. He was elected MP for North Norfolk in 1997 and became CEO and Deputy Chair of the Conservative Party.
He served as Chair of Norfolk and Norwich University Hospitals NHS Foundation Trust from 2002–2012 before becoming Chair of the Care Quality Commission. In 2015, he was appointed Parliamentary Under Secretary of State for Health and created a Life Peer. In December 2016, he was appointed as Parliamentary Under Secretary of State at the Department of Business, Energy & Industrial Strategy, with specific responsibility for developing industrial strategy. He stepped down from this role in October 2017 to become Chair of University College London Hospitals and subsequently became Chair of NHS England, a Director of Genomics England and a member of the UK Life Sciences Council to March 2022.
He is currently Chair of Protas, a not-for-profit clinical trials business, Chair of the Cambridge Life Sciences Council, Chair of Science Capital Imperial, a venture fund aligned with Imperial College, and a member of the Novo Nordisk Sustainability Advisory Council.
The Collaborate Conference is managed by Origin Sciences Limited, company #04966495, registered office First Floor, 5 Fleet Place, London, EC4M 7RD.
